title: Circadian rhythm-dependent development of melatonin effects and tolerance to PHNO in rats.
abstract: Male Sprague-Dawley rats were given 12 days of continuous infusions of (+)-4-propyl-9-hyroxynapthoxazine (PHNO, 5microg/h), a highly selective dopamine D(2) receptor agonist, via subcutaneous ALZET((R)) osmotic pumps. Motor stimulant effects (locomotion and rearing) were monitored throughout the treatment period, including after the animals were injected with 2-iodo-melatonin (0.5 mg/kg) on days 8-10 and 13 after initiation of PHNO infusions. The rats (maintained on 12 L:12 D cycle) developed tolerance to the motor stimulant effects of PHNO during the day, and behavioral sensitization to PHNO during the night. Arousing rats with a vehicle injection transiently blocked the daytime tolerance. A more sustained environmental noise without handling of animals, which had a stronger effect on increasing motor activity of control rats, reversed tolerance to sensitization. Therefore, graded levels of arousal produce graded increases in motor activity in rats otherwise tolerant to the effects of PHNO. Daytime tolerance to PHNO was reversed to sensitization by 2-iodo-melatonin. This effect was more than an additive effect of drug + injection procedure stress. The differential development of nocturnal sensitization and diurnal tolerance to PHNO effects on motor activity may depend upon circadian rhythms in melatonin release, as well as on state of arousal.
authors.affiliation: Department of Psychology, University of Western Australia, Nedlands, Western Australia, Australia.
authors.forename: J D
authors.initials: JD
authors.lastname: Munro
authors.forename: M T
authors.initials: MT
authors.lastname: Martin-Iverson
mesh_terms: D000818:Animals; D002940:Circadian Rhythm; D004298:Dopamine / Q000378:metabolism; D018491:Dopamine Agonists / Q000494:pharmacology*; D004361:Drug Tolerance; D008297:Male; D008550:Melatonin / Q000031:analogs & derivatives / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D010078:Oxazines / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017447:Receptors, Dopamine D1 / Q000187:drug effects
chemical_list: D018491:Dopamine Agonists; D010078:Oxazines; D017447:Receptors, Dopamine D1; C042631:naxagolide; C044556:2-iodomelatonin; D008550:Melatonin; D004298:Dopamine